Prediction of homologous recombination deficiency identifies colorectal tumors sensitive to PARP inhibition
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Prediction of homologous recombination deficiency identifies colorectal tumors sensitive to PARP inhibition ; volume:8 ; number:1 ; day:14 ; month:10 ; year:2024 ; pages:1-9 ; date:12.2024
npj precision oncology ; 8, Heft 1 (14.10.2024), 1-9, 12.2024
- Urheber
-
Corti, Giorgio
Buzo, Kristi
Berrino, Enrico
Miotto, Martina
Aquilano, Maria Costanza
Lentini, Marilena
Bellomo, Sara Erika
Lorenzato, Annalisa
Bartolini, Alice
Mauri, Gianluca
Lazzari, Luca
Russo, Mariangela
Nicolantonio, Federica Di
Siena, Salvatore
Marsoni, Silvia
Marchiò, Caterina
Bardelli, Alberto
Arena, Sabrina
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41698-024-00706-7
- URN
-
urn:nbn:de:101:1-2501012102560.374946180247
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
17.03.2026, 14:32 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Corti, Giorgio
- Buzo, Kristi
- Berrino, Enrico
- Miotto, Martina
- Aquilano, Maria Costanza
- Lentini, Marilena
- Bellomo, Sara Erika
- Lorenzato, Annalisa
- Bartolini, Alice
- Mauri, Gianluca
- Lazzari, Luca
- Russo, Mariangela
- Nicolantonio, Federica Di
- Siena, Salvatore
- Marsoni, Silvia
- Marchiò, Caterina
- Bardelli, Alberto
- Arena, Sabrina
- SpringerLink (Online service)
Ähnliche Objekte (12)
Homologous Recombination Deficiency Unrelated to Platinum and PARP Inhibitor Response in Cell Line Libraries
Homologous recombination deficiency in breast cancer
PALB2 or BARD1 loss confers homologous recombination deficiency and PARP inhibitor sensitivity in prostate cancer
Correlation of homologous recombination deficiency induced mutational signatures with sensitivity to PARP inhibitors and cytotoxic agents
Leveraging homologous recombination repair deficiency in sarcoma
Targeting homologous recombination deficiency in uterine leiomyosarcoma
Homologous recombination deficiency in epithelial ovarian cancer
Pan-cancer landscape of homologous recombination deficiency
ATR, CHK1 and WEE1 inhibitors cause homologous recombination repair deficiency to induce synthetic lethality with PARP inhibitors
Functional RECAP (REpair CAPacity) assay identifies homologous recombination deficiency undetected by DNA-based BRCAness tests
PLK1 overexpression suppresses homologous recombination and confers cellular sensitivity to PARP inhibition
Multi-scale characterisation of homologous recombination deficiency in breast cancer
Homologous Recombination Deficiency Unrelated to Platinum and PARP Inhibitor Response in Cell Line Libraries
Homologous recombination deficiency in breast cancer
PALB2 or BARD1 loss confers homologous recombination deficiency and PARP inhibitor sensitivity in prostate cancer
Correlation of homologous recombination deficiency induced mutational signatures with sensitivity to PARP inhibitors and cytotoxic agents
Leveraging homologous recombination repair deficiency in sarcoma
Targeting homologous recombination deficiency in uterine leiomyosarcoma
Homologous recombination deficiency in epithelial ovarian cancer
Pan-cancer landscape of homologous recombination deficiency
ATR, CHK1 and WEE1 inhibitors cause homologous recombination repair deficiency to induce synthetic lethality with PARP inhibitors
Functional RECAP (REpair CAPacity) assay identifies homologous recombination deficiency undetected by DNA-based BRCAness tests
PLK1 overexpression suppresses homologous recombination and confers cellular sensitivity to PARP inhibition
Multi-scale characterisation of homologous recombination deficiency in breast cancer
Homologous Recombination Deficiency Unrelated to Platinum and PARP Inhibitor Response in Cell Line Libraries
Homologous recombination deficiency in breast cancer
PALB2 or BARD1 loss confers homologous recombination deficiency and PARP inhibitor sensitivity in prostate cancer
Correlation of homologous recombination deficiency induced mutational signatures with sensitivity to PARP inhibitors and cytotoxic agents
Leveraging homologous recombination repair deficiency in sarcoma
Targeting homologous recombination deficiency in uterine leiomyosarcoma
Homologous recombination deficiency in epithelial ovarian cancer
Pan-cancer landscape of homologous recombination deficiency
ATR, CHK1 and WEE1 inhibitors cause homologous recombination repair deficiency to induce synthetic lethality with PARP inhibitors
Functional RECAP (REpair CAPacity) assay identifies homologous recombination deficiency undetected by DNA-based BRCAness tests
PLK1 overexpression suppresses homologous recombination and confers cellular sensitivity to PARP inhibition